Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franco Trevisani

Showing results (31-40 of 208) with videos related to

Pageof 21
Sort By:
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 17, 2016
Length time bias in surveillance for hepatocellular carcinoma and how to avoid itAlessandro Cucchetti, Francesca Garuti, Antonio Daniele Pinna, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 16, 2009
Hepatocellular carcinoma in non-cirrhotic liver: a reappraisalFranco Trevisani, Marta Frigerio, Valentina Santi, et al.
Hepatology (Baltimore, Md.)|October 31, 2018
ReplyAlessandro Vitale, Fabio Farinati, Mauro Borzio, et al.
Cancer Letters|December 3, 2014
De novo hepatocellular carcinoma of liver allograft: a neglected issueFranco Trevisani, Francesca Garuti, Alessandro Cucchetti, et al.
Tumori|April 16, 2016
Osteonecrosis of the jaw during sorafenib therapy for hepatocellular carcinomaFrancesca Garuti, Vittoria Camelli, Luca Spinardi, et al.
Journal of Hepatology|January 31, 2012
TACE treatment in hepatocellular carcinoma: what should we do now?Fabio Farinati, Anna Giacomin, Veronica Vanin, et al.
Liver Cancer|December 21, 2016
Hepatocellular Carcinoma: Therapeutic Guidelines and Medical TreatmentMasatoshi Kudo, Franco Trevisani, Ghassan K Abou-Alfa, et al.
Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches|August 21, 2023
Response to: "Comment on Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma"Simone Famularo, Matteo Donadon, Federica Cipriani, et al.
European Radiology|February 5, 2011
Contribution of the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI to Dynamic MRI in the detection of hypovascular small (≤ 2 cm) HCC in cirrhosisRita Golfieri, Matteo Renzulli, Vincenzo Lucidi, et al.
The American Journal of Gastroenterology|June 9, 2007
Hepatocellular carcinoma: trends of incidence and survival in Europe and the United States at the end of the 20th centuryRiccardo Capocaccia, Milena Sant, Franco Berrino, et al.
Pageof 21

Showing results (31-40 of 208) with videos related to

Sort By:
Pageof 21
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 17, 2016
Length time bias in surveillance for hepatocellular carcinoma and how to avoid itAlessandro Cucchetti, Francesca Garuti, Antonio Daniele Pinna, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 16, 2009
Hepatocellular carcinoma in non-cirrhotic liver: a reappraisalFranco Trevisani, Marta Frigerio, Valentina Santi, et al.
Hepatology (Baltimore, Md.)|October 31, 2018
ReplyAlessandro Vitale, Fabio Farinati, Mauro Borzio, et al.
Cancer Letters|December 3, 2014
De novo hepatocellular carcinoma of liver allograft: a neglected issueFranco Trevisani, Francesca Garuti, Alessandro Cucchetti, et al.
Tumori|April 16, 2016
Osteonecrosis of the jaw during sorafenib therapy for hepatocellular carcinomaFrancesca Garuti, Vittoria Camelli, Luca Spinardi, et al.
Journal of Hepatology|January 31, 2012
TACE treatment in hepatocellular carcinoma: what should we do now?Fabio Farinati, Anna Giacomin, Veronica Vanin, et al.
Liver Cancer|December 21, 2016
Hepatocellular Carcinoma: Therapeutic Guidelines and Medical TreatmentMasatoshi Kudo, Franco Trevisani, Ghassan K Abou-Alfa, et al.
Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches|August 21, 2023
Response to: "Comment on Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma"Simone Famularo, Matteo Donadon, Federica Cipriani, et al.
European Radiology|February 5, 2011
Contribution of the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI to Dynamic MRI in the detection of hypovascular small (≤ 2 cm) HCC in cirrhosisRita Golfieri, Matteo Renzulli, Vincenzo Lucidi, et al.
The American Journal of Gastroenterology|June 9, 2007
Hepatocellular carcinoma: trends of incidence and survival in Europe and the United States at the end of the 20th centuryRiccardo Capocaccia, Milena Sant, Franco Berrino, et al.
Pageof 21